APO RESEARCH · REPORT
In-Vitro Colorectal Cancer Screening Tests
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
Product & engineering
Understand the product.
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
Selected research
Industry Research
In-Vitro Colorectal Cancer Screening Tests Industry Research Report 2026
Market perspective
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
The industry's leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.
Report Scope
Read the full market overview
This report quantifies the global In-Vitro Colorectal Cancer Screening Tests market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to In-Vitro Colorectal Cancer Screening Tests.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In-Vitro Colorectal Cancer Screening Tests Market by Company
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
In-Vitro Colorectal Cancer Screening Tests Segment by Type
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
In-Vitro Colorectal Cancer Screening Tests Segment by Application
Hospital and Clinics
Ambulatory
Home Care
In-Vitro Colorectal Cancer Screening Tests Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Colorectal Cancer Screening Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Colorectal Cancer Screening Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Colorectal Cancer Screening Tests.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-Vitro Colorectal Cancer Screening Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biomarker Tests
- Fecal Occult Blood Tests
- CRC DNA Screening Tests
Applications
- Hospital and Clinics
- Ambulatory
- Home Care
Companies covered
- Alere(Abbott)
- Beckman Coulter
- Siemens Healthcare
- Eiken Chemical
- Hitachi Chemical (Kyowa Medex)
- Clinical Genomics Pty Ltd (Quest Diagnostics)
- Sysmex
- QIAGEN
- R-Biopharm
- Immunostics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 In-Vitro Colorectal Cancer Screening Tests by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Biomarker Tests
- 2.2.3 Fecal Occult Blood Tests
- 2.2.4 CRC DNA Screening Tests
- 2.3 In-Vitro Colorectal Cancer Screening Tests by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital and Clinics
- 2.3.3 Ambulatory
- 2.3.4 Home Care
- 2.4 Assumptions and Limitations
3 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Type
- 3.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Type (2021-2026)
- 3.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Type (2027-2032)
4 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Application
- 4.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Application (2021-2026)
- 4.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Perspective (2021-2032)
- 5.2 Global In-Vitro Colorectal Cancer Screening Tests Growth Trends by Region
- 5.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Region (2021-2026)
- 5.2.3 In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Region (2027-2032)
- 5.3 In-Vitro Colorectal Cancer Screening Tests Market Dynamics
- 5.3.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
- 5.3.2 In-Vitro Colorectal Cancer Screening Tests Market Drivers
- 5.3.3 In-Vitro Colorectal Cancer Screening Tests Market Challenges
- 5.3.4 In-Vitro Colorectal Cancer Screening Tests Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue
- 6.1.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue (2021-2026)
- 6.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Players (2021-2026)
- 6.2 Global In-Vitro Colorectal Cancer Screening Tests Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of In-Vitro Colorectal Cancer Screening Tests Head Office and Area Served
- 6.4 Global In-Vitro Colorectal Cancer Screening Tests Players, Product Type & Application
- 6.5 Global In-Vitro Colorectal Cancer Screening Tests Manufacturers Established Date
- 6.6 Global In-Vitro Colorectal Cancer Screening Tests Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 7.2 North America In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 7.4 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 8.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 8.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 9.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 9.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 10.2 South America In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 10.4 South America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 11.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 11.4 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Alere(Abbott)
- 12.1.1 Alere(Abbott) Company Information
- 12.1.2 Alere(Abbott) Business Overview
- 12.1.3 Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.1.5 Alere(Abbott) Recent Developments
- 12.2 Beckman Coulter
- 12.2.1 Beckman Coulter Company Information
- 12.2.2 Beckman Coulter Business Overview
- 12.2.3 Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.2.5 Beckman Coulter Recent Developments
- 12.3 Siemens Healthcare
- 12.3.1 Siemens Healthcare Company Information
- 12.3.2 Siemens Healthcare Business Overview
- 12.3.3 Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.3.5 Siemens Healthcare Recent Developments
- 12.4 Eiken Chemical
- 12.4.1 Eiken Chemical Company Information
- 12.4.2 Eiken Chemical Business Overview
- 12.4.3 Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.4.5 Eiken Chemical Recent Developments
- 12.5 Hitachi Chemical (Kyowa Medex)
- 12.5.1 Hitachi Chemical (Kyowa Medex) Company Information
- 12.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
- 12.5.3 Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
- 12.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
- 12.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Information
- 12.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
- 12.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
- 12.7 Sysmex
- 12.7.1 Sysmex Company Information
- 12.7.2 Sysmex Business Overview
- 12.7.3 Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.7.5 Sysmex Recent Developments
- 12.8 QIAGEN
- 12.8.1 QIAGEN Company Information
- 12.8.2 QIAGEN Business Overview
- 12.8.3 QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.8.5 QIAGEN Recent Developments
- 12.9 R-Biopharm
- 12.9.1 R-Biopharm Company Information
- 12.9.2 R-Biopharm Business Overview
- 12.9.3 R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.9.5 R-Biopharm Recent Developments
- 12.10 Immunostics
- 12.10.1 Immunostics Company Information
- 12.10.2 Immunostics Business Overview
- 12.10.3 Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2021-2026)
- 12.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 12.10.5 Immunostics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst